0 CHECKOUT

PRODUCT FILTERS

REGION

2,218
1,442
1,439
1,349
1,349

COUNTRY

1,334
147
89
87
86

CATEGORIES

  • 336
  • 322
  • 262
  • 248
  • 215
  • 196
  • 194
  • 159
  • 150
  • 145
  • 144
  • 134
  • 110
  • 104
  • 49

PRICE

616
1,203
2,202
4,919

PUBLISHED

247
468
2,617
4,919

PRODUCT TYPE

4,068
362
261
173
52
2
1

Oncology Drugs Market Research Reports

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Global T-Cell Lymphoma Market & Clinical Pipeline Insight

Immune system consists of various cells that impart resistance to body against foreign entities. They also prevent the development of aberrant cells in the body to maintain its normal functioning. However,...

Published:  March 2016
Price:  From

Cancer Bundle

The Cancer Bundle offers a 15% discount off the total transaction price for the following reports being purchased simultaneously: - Biomarker Technology Platforms for Cancer Diagnoses and Therapies -...

Published:  January 2016
Price:  From

T-Cell Immunotherapy Market, 2015-2030

This report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the...

Published:  October 2015
Price:  From

Global Cancer Pain Therapeutics Market 2015-2019

About Cancer Pain Therapeutics Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's...

Published:  January 2016
Price:  From

Global Immunotherapy Drugs 2016-2020

About Immunotherapy Drugs Immunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully...

Published:  March 2016
Price:  From

Colorectal Cancer Therapeutics Market in APAC 2015-2019

About colorectal cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature...

Published:  December 2015
Price:  From

Global Antibody Drug Conjugate Market & Pipeline Insight 2020

Pharmaceutical companies are trying to develop better therapeutics in order to overcome large unmet medical necessities. Currently available therapeutics suffers from various caveats like low specificity,...

Published:  August 2015
Price:  From

Global Acute Lymphocytic/Lymphoblastic leukemia Market 2015-2019

Global Acute Lymphocytic Leukemia Market 2015-2019 Covering: An in-depth study of the acute lymphocytic leukemia market and segmentation by route of administration (oral and parenteral), by type of...

Published:  November 2015
Price:  From

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

About non-small cell lung cancer therapeutics Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading...

Published:  October 2015
Price:  From

Global Gastric Cancer Drugs Market 2016-2020

Market outlook of the global gastric cancer drugs market The market research analyst predicts the global gastric cancer drugs market to grow rapidly at a CAGR of approximately 8% during the forecast...

Published:  December 2015
Price:  From

LAMEA Oncology/Anti-cancer Drugs Market - Opportunities and Forecasts, 2014 - 2021

Oncology/Anti-cancer drugs are used for treating various cancer types for improving and prolonging a patients survival time. Biological drugs, based on monoclonal antibodies (mAbs) would emerge as a...

Published:  February 2016
Price:  From

Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019

About Chronic Lymphocytic Leukemia Chronic lymphocytic leukemia is a malignant condition characterized by increased production of lymphocytes. It has been observed that the cancer first affects B-lymphocytes...

Published:  August 2015
Price:  From

Global Retinoblastoma Treatment Market 2015-2019

About retinoblastoma Cancer occurs when normal cells transform to evade the regular cell cycle process. Retinoblastoma is a rare eye cancer. It occurs in children of age less than 15 years; the disease...

Published:  August 2015
Price:  From

Global Cervical Cancer Market 2015-2019

About cervical cancer Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified...

Published:  September 2015
Price:  From

Gastric Cancer Testing, Treatment and Prevention: Technologies and Global Markets

This report provides: - An overview of the global markets for gastric cancer testing, treatment and prevention. - Analyses of market trends, with data from 2014, estimates for 2015, and projections...

Published:  October 2015
Price:  From

Global Colorectal Cancer Diagnostics & Therapeutics Market - Segmented by diagnosis, technology and geography (2015 - 2020)

The global colorectal cancer diagnostics and therapeutics market is expected to grow at a compound annual growth rate (CAGR) of 1-5% during the forecast period of 2015-2020. The market is valued at...

Published:  March 2016
Price:  From

Global Cervical Cancer Diagnostics and Therapeutic Market - Segmented by diagnostic test, method, end user, therapy and geography (2014-2020)

The global cervical cancer market was valued at USD 2,140 million in 2015 and is expected to grow at a CAGR of 2-5% during 2015 to 2020. Cervical cancer is generally characterized by the abnormal...

Published:  March 2016
Price:  From

Global Uterine cancer therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2015-2020)

Uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, around 47,130 new cases of endometrial...

Published:  January 2016
Price:  From

Global Melanoma Diagnostics and Therapeutics Market - Segmented by type of cancer and Geography (2015-2020)

The global melanoma diagnostics and therapeutics market was valued at USD 2,662 million in 2015 and is expected to reach USD 5,450 million by 2020. Melanoma is one of the serious types of skin cancer...

Published:  January 2016
Price:  From

Global Ovarian Cancer Diagnostics and therapeutics market - segmented by type of cancer and geography (2015-2020)

The global market for ovarian cancer diagnostics and therapeutics accounted for USD 1,106 million in 2015 and is anticipated to grow at a CAGR OF 10-16% till 2020. Ovarian cancer is caused by an...

Published:  January 2016
Price:  From
Loading Indicator

Our Clients